Fewlaps SL
QuitNow!
Publisher DNA
What defines Fewlaps SL?
AI intelligence is not yet available for Fewlaps SL. The portfolio data below is up to date.
Portfolio
What does Fewlaps SL ship?
Apps
2 apps analysed
WHO-aligned health indicators establish clinical credibility
- Health milestone tracking provides strong psychological motivation for long-term smoking cessation
- Community chat environment suffers from inappropriate behavior and lack of effective moderation
Analysis in progress
Distributed across 19 markets, strongest in Europe.
Based on 1 of 2 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (4)
- Brazil1 / 1
- Canada1 / 1
- Mexico1 / 1
- United States1 / 1
Europe (8)
- France1 / 1
- Germany1 / 1
- Italy1 / 1
- Netherlands1 / 1
- Portugal1 / 1
›+3 more europe markets
- Spain1 / 1
- Turkey1 / 1
- United Kingdom1 / 1
Asia-Pacific (7)
- Australia1 / 1
- India1 / 1
- Indonesia1 / 1
- Japan1 / 1
- Singapore1 / 1
›+2 more asia-pacific markets
- South Korea1 / 1
- Vietnam1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
1
Neutral / mixed
0
Negative apps
55/100
Avg sentiment score
Rivals
Who does Fewlaps SL compete with?
The rivals identified
Nemeses(1)
Both apps target the smoking cessation market with progress tracking and behavioral support, creating direct competition for users seeking structured recovery tools.
Contenders(3)
Both apps compete for the same smoking cessation audience by offering freemium health tracking and community support features.
Both apps target the smoking cessation market, competing for users seeking recovery tools through distinct methodologies: QuitNow! uses gamification and community, while QuitSure uses a structured CBT-based program.
Both apps compete for the same smoking cessation audience by utilizing gamified health tracking and freemium monetization models.
Same space(6)
Quitz serves the same sobriety-seeking audience as QuitNow! but emphasizes daily behavioral tasks over milestone tracking.
Exhale targets the same vaping cessation market as QuitNow! with a focus on distraction-free design.
Quit Drinking addresses the same recovery-focused user base but uses a buddy-system accountability loop to drive retention.
QuitNow Smoking competes for the same cessation audience as QuitNow! but rejects gamification for clinical CBT strategies.
Quit Dipping targets the same tobacco-cessation audience as QuitNow! but focuses on self-guided preparation plans.
QUITTR competes for the same habit-recovery audience but uses a neuroscience-backed 90-day program instead of milestone gamification.
